MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
50.45
+5.18
+11.44%
After Hours: 50.17 -0.28 -0.56% 19:59 07/26 EDT
OPEN
48.27
PREV CLOSE
45.27
HIGH
50.61
LOW
47.73
VOLUME
36.64M
TURNOVER
0
52 WEEK HIGH
65.38
52 WEEK LOW
39.04
MARKET CAP
102.27B
P/E (TTM)
-16.2700
1D
5D
1M
3M
1Y
5Y
1D
Top 10 U.S. stocks with 3-month earnings momentum as net upgrades brighten: Berenberg
Seeking Alpha · 3h ago
Tech Stocks Slide On Earnings, US Economy Flexes Muscles, Small-Cap Rally Continues: This Week In The Markets
Shares of the Magnificent Seven companies all declined during the trading week. Alphabet Inc. Reported stronger-than-expected earnings and revenue, but missed on YouTube advertising revenue. Tesla Inc. Missed quarterly earnings forecasts, leading to the worst week of the year for the tech giant's stock. The U.S. Economy grew at an annualized pace of 2.8% in the second quarter.
Benzinga · 5h ago
Sector Update: Health Care Stocks Rise in Afternoon Trading
NASDAQ · 7h ago
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
The Dow Jones Industrial Average surged 1.9% on Friday. In June, inflation dropped to 2.5% year-on-year, below the Fed's 2% target. The tech-heavy Nasdaq 100 rebounded from a negative weekly close. Homebuilders rose over 3% for the day, reaching all-time highs.
Benzinga · 7h ago
Why Bristol Myers Squibb Jumped Nearly 10% on Friday
Bristol Myers Squibb's stock is up 9.6% after a surprisingly strong second-quarter report. The company's newer drugs like Opdivo and Yervoy are helping to drive sales. The pharmaceutical company is still undervalued compared to its potential.
The Motley Fool · 8h ago
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Saia, Inc. Fell 18.6% to $398.01 on Friday. The company reported worse-than-expected second-quarter financial results. BurgerFi International and Windtree Therapeutics were among the stocks moving in today's mid-day session.
Benzinga · 8h ago
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
Bristol Myers Squibb (BMY 8.17%) Q2 2024 Earnings Call will be held on Thursday, July 26, 2024. The company will hold a conference call to discuss the second-quarter 2024 results. Chris Boerner, the company's chairman and chief executive officer, will be on the call.
The Motley Fool · 9h ago
Bristol-myers Squibb Co FY24 Annual Capital Expenditures Are Expected To Be About $1.4B
Benzinga · 9h ago
More
About BMY
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.